ANSWERING THE COVID-19 CALL TO ACTION: SavantX Dataset Search and Analysis Technology Offered at No-Cost to Researchers, Scientists, and Medical Professionals

10-Apr-2020 9:00 AM EDT, by Savonix Inc.

 

 

JACKSON HOLE, Wyo., April 9, 2020 /PRNewswire/ -- In response to the COVID-19 global pandemic, SavantX has deployed a no-cost AI-enabled web application to help medical and research professionals rapidly search, analyze and visualize the CORD-19 dataset to gain deep insight into hidden relationships within the data and answer important questions with no data science experience necessary.

Context: A Call to Action to the Tech Community was made on March 16 by The White House Office of Science and Technology Policy. The COVID-19 Open Research Dataset (CORD-19) currently encompasses over 47,000 articles released by a collaboration with the National Library of Medicine (NLM) at the National Institutes of Health, Microsoft, Chan Zuckerberg Initiative (CZI), Allen Institute for AI, and Georgetown University's Center for Security and Emerging Technology (CSET). The literature encompasses COVID-19, the Coronavirus group, and SARS-CoV-2.

According to SavantX CEO Ed Heinbockel, "SavantX offers a powerful cloud-based tool kit for researchers working with the CORD-19 dataset to quickly analyze complex data related to COVID-19 and visualize hidden relationships that may otherwise not be recognized without AI. Making this technology available at no cost will hopefully enable researchers and scientists to utilize it immediately in their quest for answers to critically important questions about the COVID-19 pandemic."

The SavantX PRO web application is optimized to use with the CORD-19 Dataset and offers a glimpse into the SavantX PRO enterprise application that encompasses a powerful Artificial Intelligence (AI) and Machine Learning (ML) driven approach. This comprehensive, advanced analytics solution is complete with data visualization tools to aid in revealing hidden relationships in the data. SavantX is offering the SavantX PRO COVID-19 search and discovery tool as a free resource for coronavirus researchers and the medical community-at-large.

SavantX's lineage includes open-source intelligence gathering tools for the US government. The patented technologies that drive SavantX PRO reveal hidden relationships and connect insights across data.

Researchers and scientists can register at:
https://savantx.com/covid-19/

 


 

MEDIA CONTACT
Register for reporter access to contact details


Filters close

Showing results

110 of 6084
Newswise: Public
Released: 28-Jul-2021 2:45 PM EDT
Highly Potent, Stable Nanobodies Stop SARS-CoV-2
Max Planck Society (Max-Planck-Gesellschaft)

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants.

Newswise: Public
Released: 28-Jul-2021 2:20 PM EDT
Psychological Consequences of COVID-19 in Health Care
University of Bonn

Physicians, nursing staff, medical technical assistants, and pastoral workers in hospitals: they have all been placed under severe strain by the Covid-19 pandemic.

Newswise: Public
Released: 28-Jul-2021 2:10 PM EDT
Why Lockdown in Africa Does Not Work as a First COVID-19 Pandemic Response
University of Johannesburg

In an African pandemic it is more productive to consider lockdowns, after using other non-medical measures first, Especially in countries with high levels of poverty and corruption, says Prof Nicholas Ngepah, a Professor of Economics at the University of Johannesburg in South Africa.

Newswise:Video Embedded how-to-talk-with-people-who-are-not-vaccinated-against-covid-19
VIDEO
Released: 28-Jul-2021 1:40 PM EDT
How to Talk With People Who Are Not Vaccinated Against COVID-19
Cedars-Sinai

Even though she has asthma, putting her at higher risk for severe complications from COVID-19, Angela Reeves-Flores, 33, waited until a week ago to get vaccinated.

Newswise: Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Released: 28-Jul-2021 12:50 PM EDT
Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Cornell University

A new study from Cornell University finds the nationwide lockdown India imposed last year in response to COVID-19 caused disruptions that negatively impacted women’s nutrition.

Released: 28-Jul-2021 12:00 PM EDT
MD Anderson Research Highlights for July 28, 2021
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a newly discovered protein that controls B cell survival, understanding epigenetic changes in malignant peripheral nerve sheath tumors (MPNSTs) and melanoma, identifying a protein that protect genome stability, developing novel cell therapies for COVID-19, a new option for treating neuropathic pain, exosome delivery of CRISPR/Cas9 to pancreatic cancer, discovering how cancer cells tolerate aneuploidy and the role of health disparities in long-term survival of adolescent and young adult patients with Hodgkin lymphoma.

Released: 28-Jul-2021 11:30 AM EDT
Study Reveals Characteristics of SARS-CoV-2 Spike Protein
University of Kentucky

A new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry provides foundational information about SARS-CoV-2’s spike protein.

access_time Embargo lifts in 2 days
Embargo will expire: 4-Aug-2021 9:00 AM EDT Released to reporters: 28-Jul-2021 11:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Aug-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
Released: 28-Jul-2021 10:15 AM EDT
UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
University of Illinois Chicago

Researchers at the University of Illinois Chicago are developing a potential treatment for COVID-19, thanks to a $6 million technology and therapeutic development award from the U.S. Department of Defense supporting pre-clinical animal studies.

Newswise: Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Released: 28-Jul-2021 8:55 AM EDT
Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Chulalongkorn University

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.


Showing results

110 of 6084

close
1.28699